Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
0.363
+0.010 (2.89%)
At close: Dec 20, 2024, 4:00 PM
0.372
+0.009 (2.56%)
After-hours: Dec 20, 2024, 5:46 PM EST
Relmada Therapeutics Market Cap
Relmada Therapeutics has a market cap or net worth of $10.95 million as of December 20, 2024. Its market cap has decreased by -85.80% in one year.
Market Cap
10.95M
Enterprise Value
-43.17M
1-Year Change
-85.80%
Ranking
Category
Stock Price
$0.36
Market Cap Chart
Since September 30, 2015, Relmada Therapeutics's market cap has decreased from $56.60M to $10.95M, a decrease of -80.65%. That is a compound annual growth rate of -16.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 11.00M | -91.17% |
| Dec 29, 2023 | 124.60M | 18.67% |
| Dec 30, 2022 | 105.00M | -73.42% |
| Dec 31, 2021 | 395.00M | -24.17% |
| Dec 31, 2020 | 520.90M | 30.00% |
| Dec 31, 2019 | 400.70M | 1,125.38% |
| Dec 31, 2018 | 32.70M | 247.87% |
| Dec 29, 2017 | 9.40M | -28.24% |
| Dec 30, 2016 | 13.10M | -54.67% |
| Dec 31, 2015 | 28.90M | -48.94% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immuron | 11.19M |
| Zhongchao | 11.17M |
| Lyra Therapeutics | 11.13M |
| Sensei Biotherapeutics | 10.82M |
| Turnstone Biologics | 10.67M |
| China Jo-Jo Drugstores | 10.63M |
| Talphera | 10.52M |
| Ensysce Biosciences | 10.37M |